Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
An HIV vaccine, even if modestly effective, could still contribute greatly to efforts to drive down rate of new HIV infections worldwide.
A new type of syringe apparently falls short at lowering the risk of hepatitis C virus transmission.
Syringe exchange and opioid substitution programs in New York City have practically eliminated HIV infection among white injection drug users,...
Untreated HIV causes changes to cellular DNA that are akin to 14 years of aging, which may partially explain the early onset of age-related di...
The World Health Organization has called for all hospitals and clinics worldwide to use “smart syringes,” which prevent a second u...
The cost-effectiveness and capacity to prevent HIV among gay and bi men of Truvada as pre-exposure prophylaxis (PrEP) varies widely...
A majority of people taking antiretrovirals to treat HIV could switch to newer regimens with improved side effect profiles.
Infection with herpes simplex virus 2 is propelling significant increases in the prevalence of HIV among non-injecting drug users in New York...
Higher HIV viral loads are linked to a faster depletion of CD4 cells among South Africans not taking antiretrovirals.
Smoking is detrimental to the immune systems of HIV-positive people taking antiretroviral therapy.
People living with HIV are at increased risk of melanoma irrespective of antiretroviral use, especially if they are white skinned.
Despite an undetectable plasma viral load, HIV may be intermittently present in men’s semen, with fluctuations occurring in the course of only...
British Columbia offers solid, real-world evidence that the HIV treatment as prevention (TasP) strategy is highly effective.
Various behavioral, health, educational and economic factors are linked to recent HIV infection among black men who have sex with men.
New HIV infections in black men who have sex with men are linked to unemployment, lower socioeconomic status and other STIs.
Taking Truvada as pre-exposure prophylaxis (PrEP) did not lead HIV-negative people in a large study to take increased sexual risks...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.